Pursuant to Regulation 30 read with Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aarti Pharmalabs has informed that the Company (‘APL’) has executed an Addendum to the Subscription and Shareholders Agreement entered into between the Company and the Hemant Bandodkar & family (Bandodkars) pursuant to which Ganesh Polychem (GPL) would be Joint Venture Company of APL with effect from the close of business hours of 31st March 2025. The details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023, is given in Annexure 'A' attached to this letter.
The above information is a part of company’s filings submitted to BSE.
